State of Play of Physiotherapy in the Postoperative Management of Prostate Cancer : Prospective, Monocentric, National Survey, Aiming to Explore the Technics of Physiotherapy (PREduKiné)

NCT06815055 | Not Yet Recruiting

• 1 other identifier: 2022-010
• Study Type: observational
• Target: 510
• Locations: 0 countries
• Sites: N/A

Brief Summary

In France, a considerable number of radical prostactectomy for cancer is carried out every year.This number was estimated at 20.000 in 2016.This surgery may have negative impact on the continence's subjects and their quality of life. The rehabilitation, preoperative or postoperative, practiced by a physiotherapist, can reduced those side effects. The rehabilitation techniques are many and their efficacy may differ. No study where found about the clasification and evaluation of those rehabilitation techniques.

Conditions

Radical Prostatectomies; Rehabilitation Outcome; Prostate Cancer; Prostate Cancer Surgery; Rehabilitation Exercise

Keywords

radical prostatectomy; rehabilitation; continence; quality of life

Outcome Measures

Primary Outcomes (1)

• Set up homogeneous groups of subjects (clusters)

  The primary outcome is a survey questionning the subject about the rehabilitation techniques realised during the post operative period. This survey will be asked during a phone interview directed by investgator.

  It will take place around six months after the surgery.

Interventions

Quality of life questionnary OTHER

Subjects will be call 1 month and 6 months after prostetectomy to evaluate the type of reeducation received and they will be evaluated with the help of QoL questionnaries : KHQ-HR QoL and ICIQ-SF QoL

Eligibility Criteria

• Age: 18 Years+
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The population concerned by the study is national french territory. Subjects must have an postoperative follow up performing by an urologist.

You may qualify if:

• men who has undergone a radical prostactectomy to treat a prostatic adenocarcinoma
• having a follow up postoperative consultation between one and two month after the surgery
• being able to answer to respond the questions during the interviews
• agreeing to participate by signing informed consent form

You may not qualify if:

• undergoing an adjuvant therapy as radiotherpy, chemotherapy and hormone therapy
• Refusing to take part in the study

Sponsors & Collaborators

• Centre Hospitalier de Roubaix: lead

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases

Central Study Contacts

Camille Trouillet, Clinical Research Associate

CONTACT

0033320993131; camille.trouillet@ch-roubaix.fr

Maxence Mokeddem, Clinical Research Assistant

CONTACT

0033320993131; maxence.mokeddem@ch-roubaix.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 4, 2025
• First Posted: February 7, 2025
• Study Start: June 1, 2025
• Primary Completion (Estimated): December 30, 2026
• Study Completion (Estimated): December 30, 2026
• Last Updated: June 5, 2025

Record last verified: 2025-06